Summary Background Hepatitis C virus (HCV) infection is highly prevalent among HIV-1-
infected individuals, but its contribution to the morbidity and mortality of coinfected patients …

Background The efficacy of highly active antiretroviral therapy (HAART) in suppression of
HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in …

Objectives: To examine trends in disease progression and survival among patients enrolled
in the Swiss HIV cohort study during 1988–96 and to assess the influence of new …

Background Mortality among HIV‐infected persons is decreasing, and causes of death are
changing. Classification of deaths is hampered because of low autopsy rates, frequent …

Background Data on adverse events to antiretroviral treatment have been recorded in
clinical trials, post-marketing analyses, and anecdotal reports. Such data might not be an up …

Objective The amount of HIV in semen likely influences infectiousness. Antiretroviral therapy
decreases HIV-RNA in semen, but data on HIV concentrations in semen in a large cohort of …

Objectives To compare the use of co-medication, the potential drug–drug interactions
(PDDIs) and the effect on antiretroviral therapy (ART) tolerability and efficacy in HIV-infected …

Background It is unclear whether primary prophylaxis against Pneumocystis carinii
pneumonia can be discontinued in patients infected with the human immunodeficiency virus …

Objective To assess the impact of primary HIV infection (PHI) on the spread of HIV and the
temporal trends in transmission of HIV drug resistance between 1996 and 1999 in …

The prevalence, clinical presentation, and risk factors for hyperlactatemia among patients
receiving antiretroviral therapy was determined during a 1-month period for patients in the …